Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Survival in multiple sclerosis.

S Poser1, J F Kurtzke, W Poser

  • 1Multiple Sclerosis Clinic, Georg-August University of Göttingen, F.R.G.

Journal of Clinical Epidemiology
|January 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Gulf War era multiple sclerosis cohort: 3. Early clinical features.

Acta neurologica Scandinavica·2017
Same author

ELISA-Based Crossmatching Allowing the Detection of Emerging Donor-Specific Anti-HLA Antibodies through the Use of Stored Donors' Cell Lysates.

Case reports in transplantation·2015
Same author

Serum proteomic analysis of a pre-symptomatic multiple sclerosis cohort.

European journal of neurology·2014
Same author

Artificially Positive Crossmatches Not Leading to the Refusal of Kidney Donations due to the Usage of Adequate Diagnostic Tools.

Case reports in transplantation·2013
Same author

Generation of donor-specific anti-human leukocyte antigen antibodies after the transplantation of a fully matched kidney allograft and its impact on the selection of a subsequent renal regraft: a case report.

Transplantation proceedings·2012
Same author

General insufficiency of the classical CDC-based crossmatch to detect donor-specific anti-HLA antibodies leading to invalid results under recipients' medical treatment or underlying diseases.

Histology and histopathology·2011
Same journal

A comparison of five statistical methods used to analyse longitudinal EORTC QLQ-C30 quality of life scores in randomised controlled trials: a simulation study.

Journal of clinical epidemiology·2026
Same journal

Sample Size Determination for Decision-centered Pragmatic Trials.

Journal of clinical epidemiology·2026
Same journal

Many multicenter randomized controlled trials do not account for center effect: a methodological review.

Journal of clinical epidemiology·2026
Same journal

Patient Acceptability of the Modified Zelen Approach to Randomized Trials - A Survey of the CAPS THA Cohort.

Journal of clinical epidemiology·2026
Same journal

Corrigendum to SPICE-GRADE: simultaneous processing of indirect causal evidence in complex pathways using GRADE - an exploratory case study. [Journal of Clinical Epidemiology, 194C (2026) 112219].

Journal of clinical epidemiology·2026
Same journal

Small numbers of clusters in cluster randomised trials: a scoping review of problems and proposed solutions.

Journal of clinical epidemiology·2026
See all related articles

Survival for multiple sclerosis (MS) patients shows a substantial life expectancy reduction. However, differences in survival by sex and age at onset reflect general population trends, not the disease itself.

Area of Science:

  • Neurology
  • Epidemiology

Background:

  • Multiple sclerosis (MS) significantly impacts patient survival.
  • Understanding survival rates is crucial for patient care and prognosis.

Purpose of the Study:

  • To calculate and compare survival rates in two distinct cohorts of multiple sclerosis patients.
  • To investigate the influence of sex and age at onset on survival in MS.

Main Methods:

  • Survival analysis was performed on a population-based series (n=224) and a hospital-based series (n=1429) of MS patients.
  • Observed survival was compared to expected survival using population life tables.
  • Subgroup analyses were conducted based on sex and age at onset.

Main Results:

  • Median survival was 35-42 years in the epidemiologic series and 30 years in the hospital series.

Related Experiment Videos

  • While the hospital series showed differences favoring females and younger onset, subgroup survival ratios mirrored general population expectations.
  • Overall life expectancy was substantially reduced in MS patients.

    • Conclusions:

    • The observed survival differences by sex and age at onset in MS patients are likely influenced by general demographic survival patterns rather than disease-specific factors.
    • MS leads to a significant reduction in life expectancy, but demographic factors play a key role in observed survival variations.